Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In the United States, the Food and Drug Administration (FDA) classified BPC-157 as Category 2 for compounding due to adverse immune system reactions, peptide-related impurities and insufficient safety information to determine whether it would cause harm when administered to humans
Abstract Parkinsons disease (PD) is an age-related neurodegenerative disorder characterized by the progressive degeneration of dopaminergic neurons, with mitochondrial dysfunction playing a critical role in its pathogenesis
moving air introduces contaminants
You have Von Hippel-Lindau (vHL) Disease: This rare genetic disorder predisposes individuals to blood-vessel tumors
Our Certificate of Analysis (COA) includes individual HPLC purity analysis for both BPC-157 and TB-500, mass spectrometry confirmation of each peptide, endotoxin testing, and sterility verification
Personalized protocols, real results Our experienced medical providers create personalized peptide protocols tailored to your goals combining advanced regenerative medicine, hormone optimization, and evidence-based treatments to deliver real, measurable results
